Next H1 preview: Where next for the Next share price?

Next has seen an explosion in sales since it reopened stores in April, prompting it to raise expectations for the rest of the year. We look at what to expect from the earnings and consider how Next shares could react.

Stocks (1)

When will Next release H1 results?

Next is scheduled to release interim earnings on the morning of Wednesday September 29.

Next H1 earnings preview: what to expect from the results

Next has proven to be one of the most resilient players in what has been a challenging 18 months for retailers, thanks to its omnichannel approach that has allowed it to thrive online whilst stores were closed. However, with stores having reopened in April, analysts are anticipating a strong performance from Next in the first half.

This is demonstrated by the fact full price sales in the second quarter were 18.6% higher than two years earlier, before the pandemic hit – with Next having only expected a mild 3% rise. Next said the stronger-than-expected performance was down to pent-up demand for adult clothing, warmer-than-anticipated weather, increased domestic spending and the fact consumers are flush with money they saved during lockdown.

Analysts are expecting sales to jump to £2.17 billion in the first half from just £1.29 billion the year before, when the pandemic severely hit sales. For more context, that compares to £2.05 billion in the first half of 2019, before the pandemic hit.

Basic EPS is forecast to swing to a profit of 219.18p from the 9.0p loss booked the year before.

Investors will be keeping an eye on Next’s guidance for the full year after bumping-up its targets back in July. The company said it is aiming to deliver 6% full price sales growth rather than its initial target of 3%, and £750 million in pretax profit.

They will also be eagerly watching for any commentary on shareholder returns, having said in July that it intended to distribute around £240 million in surplus cash this year. That includes the £140 million returned through a 110p special payout that was paid in early September. However, ordinary dividends are not set to be reinstated until the next financial year covering the 12 months to the end of January 2023, but some analysts think share buybacks could come back into play in the current financial year after Next decided to repay the business rates relief it received, demonstrating its financial strength.

Next shares have fully recovered the heavy losses booked during the pandemic and trade over 16% higher than before the coronavirus crisis started back in February 2021, which has also seen it surpass the record all-time highs seen back in 2015. The 21 brokers covering Next have an average Buy rating on the stock but the target price of 8,359.1p implies there is only around 1.5% potential upside from the current share price.

Where next for the Next share price?

The Next share price has traded range bound around the all-time high for the past six months capped on the upper band by 8360p and on the lower band by 7680p.  

After rebounding off the 200 sma earlier this month, Next share price is extending gains towards the upper band at 8360p.  

The RSI is supportive of further gains whilst it remains out of overbought territory.  

A move above 8360p could expose 8400p and fresh all-time highs. 

Meanwhile, support can be seen at 7970p the 50 sma ahead of 7835p the 200 sma. A break below 7680p the lower band of the channel could see the sellers gain traction. 

Where next for the Next share price?

How to trade Next shares

You can trade Next shares with City Index in just four easy steps:

  1. Open a City Index account, or log-in if you’re already a customer.
  2. Search for ‘Next’ in our award-winning platform
  3. Choose your position and size, and your stop and limit levels
  4. Place the trade  

More from Equities


This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

StoneX Financial Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.